266 related articles for article (PubMed ID: 18665138)
1. Leukocytapheresis for the treatment of IBD.
Sigurbjörnsson FT; Bjarnason I
Nat Clin Pract Gastroenterol Hepatol; 2008 Sep; 5(9):509-16. PubMed ID: 18665138
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
[TBL] [Abstract][Full Text] [Related]
3. Addition of leukocytapheresis to steroid therapy: is it beneficial in recurrence of moderate-to-severe ulcerative colitis?
Jo Y; Matsumoto T; Mibu R; Iida M
Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S3-9. PubMed ID: 14530652
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.
Sands BE; Sandborn WJ; Feagan B; Löfberg R; Hibi T; Wang T; Gustofson LM; Wong CJ; Vandervoort MK; Hanauer S;
Gastroenterology; 2008 Aug; 135(2):400-9. PubMed ID: 18602921
[TBL] [Abstract][Full Text] [Related]
5. Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.
Domènech E; Hinojosa J; Esteve-Comas M; Gomollón F; Herrera JM; Bastida G; Obrador A; Ruiz R; Saro C; Gassull MA;
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1347-52. PubMed ID: 15606397
[TBL] [Abstract][Full Text] [Related]
6. Leukocytapheresis for treatment of IBD.
Kohgo Y; Ashida T; Maemoto A; Ayabe T
J Gastroenterol; 2003 Mar; 38 Suppl 15():51-4. PubMed ID: 12698872
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K
Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis.
Yamamoto T; Saniabadi AR; Maruyama Y; Umegae S; Matsumoto K
Dig Liver Dis; 2007 Jul; 39(7):626-33. PubMed ID: 17532273
[TBL] [Abstract][Full Text] [Related]
9. Leukocytapheresis in the treatment of inflammatory bowel disease: Current position and perspectives.
Vernia P; D'Ovidio V; Meo D
Transfus Apher Sci; 2010 Oct; 43(2):227-9. PubMed ID: 20817610
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors of efficacy of leukocytapheresis for steroid-resistant ulcerative colitis patients.
Takemoto K; Kato J; Kuriyama M; Nawa T; Kurome M; Okada H; Sakaguchi K; Shiratori Y
Dig Liver Dis; 2007 May; 39(5):422-9. PubMed ID: 17379587
[TBL] [Abstract][Full Text] [Related]
11. Centrifugal leukocytapheresis therapy for ulcerative colitis without concurrent corticosteroid administration.
Okada H; Takenaka R; Hiraoka S; Makidono C; Hori S; Kato J; Okazaki H; Kawamoto H; Mizuno M; Shiratori Y
Ther Apher Dial; 2006 Jun; 10(3):242-6. PubMed ID: 16817788
[TBL] [Abstract][Full Text] [Related]
12. Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?
Saniabadi AR; Hanai H; Suzuki Y; Ohmori T; Sawada K; Yoshimura N; Saito Y; Takeda Y; Umemura K; Kondo K; Ikeda Y; Fukunaga K; Nakashima M; Beretta A; Bjarnason I; Lofberg R
J Clin Apher; 2005 Oct; 20(3):171-84. PubMed ID: 15892107
[TBL] [Abstract][Full Text] [Related]
13. Leukocytapheresis therapy with leukocyte removal filter for inflammatory bowel disease.
Sawada K; Ohnishi K; Kosaka T; Fukui S; Yamamura M; Amano K; Satomi M; Shimoyama T
J Gastroenterol; 1995 Nov; 30 Suppl 8():124-7. PubMed ID: 8563873
[TBL] [Abstract][Full Text] [Related]
14. Selective leukocyte apheresis for the treatment of inflammatory bowel disease.
Abreu MT; Plevy S; Sands BE; Weinstein R
J Clin Gastroenterol; 2007; 41(10):874-88. PubMed ID: 18090155
[TBL] [Abstract][Full Text] [Related]
15. Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis.
D'Ovidio V; Aratari A; Viscido A; Marcheggiano A; Papi C; Capurso L; Caprilli R
Dig Liver Dis; 2006 Jun; 38(6):389-94. PubMed ID: 16569521
[TBL] [Abstract][Full Text] [Related]
16. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
[TBL] [Abstract][Full Text] [Related]
17. [Apheresis in inflammatory bowel disease].
Nos P; Domènech E
Gastroenterol Hepatol; 2009; 32(7):509-18. PubMed ID: 19608298
[TBL] [Abstract][Full Text] [Related]
18. Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy.
Nishioka C; Aoyama N; Maekawa S; Shirasaka D; Nakahara T; Tamura T; Fukagawa M; Umezu M; Abe T; Kasuga M
J Gastroenterol Hepatol; 2005 Oct; 20(10):1567-71. PubMed ID: 16174075
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of granulocyte and monocyte adsorption apheresis for ulcerative colitis: a meta-analysis.
Yoshino T; Nakase H; Minami N; Yamada S; Matsuura M; Yazumi S; Chiba T
Dig Liver Dis; 2014 Mar; 46(3):219-26. PubMed ID: 24268950
[TBL] [Abstract][Full Text] [Related]
20. Sustained remission after steroids and leukocytapheresis induced response in steroid-dependent ulcerative colitis: results at 1 year.
Cabriada JL; Ibargoyen N; Hernández A; Bernal A; Castiella A
Dig Liver Dis; 2010 Jun; 42(6):432-5. PubMed ID: 19833566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
